BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38184201)

  • 1. Developing a machine learning model for bleeding prediction in patients with cancer-associated thrombosis receiving anticoagulation therapy.
    Grdinic AG; Radovanovic S; Gleditsch J; Jørgensen CT; Asady E; Pettersen HH; Delibasic B; Ghanima W
    J Thromb Haemost; 2024 Apr; 22(4):1094-1104. PubMed ID: 38184201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score.
    de Winter MA; Dorresteijn JAN; Ageno W; Ay C; Beyer-Westendorf J; Coppens M; Klok FA; Moustafa F; Riva N; Ruiz Artacho PC; Vanassche T; Nijkeuter M
    Thromb Haemost; 2022 May; 122(5):818-829. PubMed ID: 34544170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic Treatment.
    Herrin J; Abraham NS; Yao X; Noseworthy PA; Inselman J; Shah ND; Ngufor C
    JAMA Netw Open; 2021 May; 4(5):e2110703. PubMed ID: 34019087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism.
    Klok FA; Barco S; Konstantinides SV
    Thromb Haemost; 2017 Jun; 117(6):1164-1170. PubMed ID: 28276566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations.
    Mora D; Mateo J; Nieto JA; Bikdeli B; Yamashita Y; Barco S; Jimenez D; Demelo-Rodriguez P; Rosa V; Yoo HHB; Sadeghipour P; Monreal M;
    Br J Haematol; 2023 Jun; 201(5):971-981. PubMed ID: 36942630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment.
    McBane Ii RD; Vlazny DT; Houghton D; Casanegra AI; Froehling D; Daniels P; Riaz IB; Hodge DO; Wysokinski WE
    Thromb Haemost; 2023 May; 123(5):535-544. PubMed ID: 36574777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Frei AN; Stalder O; Limacher A; Méan M; Baumgartner C; Rodondi N; Aujesky D
    Thromb Haemost; 2021 Nov; 121(11):1512-1522. PubMed ID: 33930905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
    Jiménez-Fonseca P; Gallardo E; Arranz Arija F; Blanco JM; Callejo A; Lavin DC; Costa Rivas M; Mosquera J; Rodrigo A; Sánchez Morillas R; Vares Gonzaléz M; Muñoz A; Carmona-Bayonas A
    Eur J Intern Med; 2022 Jun; 100():33-45. PubMed ID: 35227541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the VTE-BLEED score's long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry.
    Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    J Thromb Haemost; 2020 Mar; 18(3):624-632. PubMed ID: 31785073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism.
    Xi S; Liu C; Yu S; Qiu J; He S; Yi Z
    Hamostaseologie; 2023 Aug; 43(4):281-288. PubMed ID: 37137330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.
    Klok FA; Barco S; Turpie AGG; Haas S; Kreutz R; Mantovani LG; Gebel M; Herpers M; Bugge JP; Kostantinides SV; Ageno W
    Br J Haematol; 2018 Nov; 183(3):457-465. PubMed ID: 30123981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism.
    Wells PS; Tritschler T; Khan F; Anderson DR; Kahn SR; Lazo-Langner A; Carrier M; Le Gal G; Castellucci LA; Shah V; Kaatz S; Kearon C; Solymoss S; Zide R; Schulman S; Chagnon I; Mallick R; Rodger MA; Kovacs MJ
    Blood Adv; 2022 Aug; 6(15):4605-4616. PubMed ID: 35679460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding Risk Assessment in Patients with Venous Thromboembolism.
    Nopp S; Ay C
    Hamostaseologie; 2021 Aug; 41(4):267-274. PubMed ID: 33626580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies.
    Wang TF; Hill M; Mallick R; Chaudry H; Unachukwu U; Delluc A; Carrier M
    Thromb Res; 2023 Nov; 231():128-134. PubMed ID: 37857226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry.
    Yamashita Y; Morimoto T; Klok FA; Barco S; Nishimoto Y; Kato T; Ono K; Kimura T;
    J Thromb Thrombolysis; 2022 Oct; 54(3):524-534. PubMed ID: 35713842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study.
    Vedovati MC; Mancuso A; Pierpaoli L; Paliani U; Conti S; Ascani A; Galeotti G; Di Filippo F; Caponi C; Agnelli G; Becattini C
    Int J Cardiol; 2020 Feb; 301():167-172. PubMed ID: 31761402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry.
    Piovella C; Dalla Valle F; Trujillo-Santos J; Pesavento R; López L; Font L; Valle R; Nauffal D; Monreal M; Prandoni P;
    Intern Emerg Med; 2014 Dec; 9(8):847-52. PubMed ID: 24839226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer.
    Ueyama H; Miyashita H; Takagi H; Cruz C; Burger A; Briasoulis A; Kuno T
    J Thromb Thrombolysis; 2021 Jan; 51(1):102-111. PubMed ID: 32458316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.